Renova Therapeutics, a biopharmaceutical company developing gene therapy treatments for congestive heart failure and other chronic diseases, has hired Michele Martorana as Clinical Research Manager.
Martorana, a registered nurse, joins Renova Therapeutics after working as a clinical research consultant for the company. In her new role, she will co-ordinate the conduct of the company's clinical trials with multiple contract research organisations.
'Michele will be vital to our work in advancing further clinical trials, especially RT-100 for heart failure,' said Dr Richard McCloskey, Executive Vice President of Clinical Development, Renova Therapeutics. 'As we gear up for pivotal trials with this promising gene therapy candidate, she will be critical in providing hands-on support to ensure well-managed execution of this important next step for the company.'
Prior to supporting Renova Therapeutics, Martorana was a nurse at the VA Health Administration in Biloxi, Mississippi, US. She is a licensed registered nurse in California and Mississippi and holds a BSc in Nursing from the University of Southern Mississippi School of Nursing.
